Search for page Ko te ohorere
Displaying 60 - 69 of 99 results
-
Femicide and mana-wāhine: a korero to progress understanding and prevention of deaths of women and girls in Aotearoa
A background discussion paper of views of wāhine Māori representatives.
-
Maternal morbidity review toolkit: Example of a trigger list
The example of a trigger list is part of the maternal morbidity review toolkit for maternity services.
-
Maternal morbidity review toolkit: Local review process map (A3)
The local review process map is part of the maternal morbidity review toolkit for maternity services.
-
Ninth Annual Report of the Perinatal and Maternal Mortality Review Committee
This report considers perinatal and maternal mortality and morbidity from 1 January to 31 December 2013.
-
Family violence death information sheet series
These information sheets provide easy access in multiple languages to information about the nature and circumstances of family violence deaths in Aotearoa.
-
Special report on alcohol related deaths
Special Report: The involvement of alcohol consumption in the deaths of children and young people in New Zealand during the years 2005–2007
-
Low speed run over mortality report
In its Fifth Report to the Minister of Health (2009), the Child and Youth Mortality Review Committee (CYMRC) noted that systems to review non-traffic deaths are inconsistent and less well developed compared with systems to review traffic deaths.
-
Naming of Ngā Pou Arawhenua
Matua Witi Ashby gifted the name Ngā Pou Arawhenua to the Māori caucus of the mortality review committees.
-
Including whānau voices in family violence homicide in-depth reviews
Since 2019, the Family Violence Death Review Committee has been seeking the input of surviving family and whānau members as part of the in-depth review process. This article is a reflection on the process and how we can improve it.
-
Fifth report of the Perioperative Mortality Review Committee
In this fifth report, the Perioperative Mortality Review Committee has examined perioperative mortality in New Zealand during 2009–2013 for two new clinical areas of interest.